SCHEMBL9217699

SCHEMBL9217699

O=C(O)c1cccc(C(=O)c2ccc(O)c(O)c2)c1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 3/20 0.73
CA2 P00918 3/20 0.73
CA9 Q16790 3/20 0.73
L3MBTL1 Q9Y468 2/20 0.73
CA12 O43570 2/20 0.73
CA6 P23280 2/20 0.73
PTGS2 P35354 2/20 0.73
KDM4E B2RXH2 1/20 0.73
POLB P06746 1/20 0.73
GAA P10253 1/20 0.73
MAPT P10636 1/20 0.73
CA4 P22748 1/20 0.73
CA7 P43166 1/20 0.73
CA14 Q9ULX7 1/20 0.73
ATM Q13315 1/20 0.57
TDP1 Q9NUW8 1/20 0.57
SRD5A2 P31213 3/20 0.52
SIRT1 Q96EB6 1/20 0.51
FASN P49327 1/20 0.50
CNR2 P34972 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Protocatechuic Acid SCHEMBL28487427 0.88 CA12 (0.95) CA1CA2CA9L3MBTL1CA12
SCHEMBL31257839 0.86 L3MBTL1 (0.64) CA1CA2CA9L3MBTL1CA12
SCHEMBL142204 0.86 L3MBTL1 (0.64) CA1CA2CA9L3MBTL1CA12
Protocatechuic Acid SCHEMBL5137526 0.86 CA12 (0.83) CA1CA2CA9L3MBTL1CA12
SCHEMBL766131 0.85 ATM (0.76) CA1CA2CA9L3MBTL1CA12
Protocatechuic Acid SCHEMBL39435 0.85 CA12 (1.00) CA1CA2CA9L3MBTL1CA12
Protocatechuic Acid SCHEMBL30030432 0.85 CA12 (1.00) CA1CA2CA9L3MBTL1CA12
Protocatechuic Acid SCHEMBL29350008 0.85 CA12 (1.00) CA1CA2CA9L3MBTL1CA12
Protocatechuic Acid SCHEMBL27815804 0.85 CA12 (1.00) CA1CA2CA9L3MBTL1CA12
SCHEMBL9752049 0.84 HSD17B1 (0.59) CA1CA2CA9L3MBTL1CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0549621-B1 NEW LEUKOTRIENE-B4 ANTAGONISTS, PROCESS FOR PRODUCING THE SAME AND THEIR USE AS MEDICINAL DRUGS SCHERING AG (DE) 1995-09-27 EP disclosed
US-5352701-A Leukotriene-B4 antagonist compounds and their use as pharmaceutical agents SCHERING AKTIENGESELLSCHAFT (DE) 1994-10-04 US disclosed
WO-1992004311-A1 NEW LEUKOTRIENE-B4 ANTAGONISTS, PROCESS FOR PRODUCING THE SAME AND THEIR USE AS MEDICINAL DRUGS SCHERING AKTIENGESELLSCHAFT BERLIN UND BERGKAMEN (DE) 1992-03-19 WO disclosed